Pharma Mar - Combination of Lurbinectedin and Atezolizumab Demonstrated a Statistically Significant Improvement in Primary Endpoints of Overall Survival and Progression-Free Survival
Pharma Mar - 盧比內替丁和阿特祖米布的組合在總生存期和無疾病進展生存期方面表現出顯著的統計學改善
Pharma Mar - Combination of Lurbinectedin and Atezolizumab Demonstrated a Statistically Significant Improvement in Primary Endpoints of Overall Survival and Progression-Free Survival
Pharma Mar - 盧比內替丁和阿特祖米布的組合在總生存期和無疾病進展生存期方面表現出顯著的統計學改善
譯文內容由第三人軟體翻譯。